The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...
Novartis has completed its acquisition of US biopharma Chinook Therapeutics. The acquisition, which was announced in June, has a value of up to $3.5 billion.
The fallout from Russia's war with Ukraine is having a lasting impact on almost every market, including plastics in Europe, with inflation, low demand, and uncertainty...
CEFIC, the European Chemical Industry Council, expects the EU27 chemical production to decline by about 8% in 2023 compared to the previous year, with no imminent...
Shell CEO, Wael Sawan, contemplates another headquarters move amidst the introduction of windfall taxes in the UK. Questions about the state of production and energy...
Due to considerations likely to reflect objections not only from the chemical industry, the US Environmental Protection Agency (EPA) and the US Department of Justice have...
Novartis has agreed to acquire US biopharma Chinook Therapeutics for $3.5 billion. Chinook has two late-stage drugs in development – Atrasentan and Zigakibart – to treat...
There are only a few chemical and pharmaceutical companies that look back at a history of 150 years. Certainly, many companies claim such a long legacy, but if you only...
The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...
Cleanroom residues can be generated by the process, raw materials, certainly by people but a significant contributor to the residues in a cleanroom are the disinfectants...